Neurology & CNS patent intelligence

US 11026978

Compositions and methods for treating multiple sclerosis and related disorders

Finch Therapeutics Holdings LLC · Granted Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11020461

Methods and compositions for CNS delivery of arylsulfatase A

Takeda Pharmaceutical Company Limited · Granted Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10987346

Iloperidone for the treatment of schizophrenia

VANDA PHARMACEUTICALS INC. · Granted Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10953031

Compounds and methods for treating neurological and cardiovascular conditions

The Board of Regents of the University of Texas System · Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10918594

Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

The Regents of the University of California · Granted Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10900041

Antisense oligonucleotides for use in treating Alzheimer's disease

ProQR Therapeutics II B.V. · Granted Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2021005494

ANTAGONISTES DU CGRP ET DÉRIVÉS DE CLOSTRIDIALES POUR LE TRAITEMENT DE TROUBLES NEUROPSYCHIATRIQUES ET NEUROLOGIQUES

ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Thu Jan 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jan 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2021005493

ANTAGONISTES DU CGRP ET TOXINES BOTULINIQUES POUR LE TRAITEMENT DE TROUBLES INFLAMMATOIRES ET NEUROLOGIQUES

ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Thu Jan 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jan 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10889543

Fine-tune modulators of neuronal excitability for neuropsychiatric disorders

The Board of Regents of the University of Texas System · Granted Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10889625

Peptide-based methods for treating neurological injury

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10874659

Iloperidone metabolite for use in the treatment of psychiatric disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10849878

Agent exhibiting anti-stress, anxiolytic and anti-depression activity, and composition based thereon

OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU “NORMOFARM” · Granted Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10829536

Methods of promoting CNS neuronal repair by inhibiting LRP-1

The Regents of the University of California · Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10808247

Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach

Phio Pharmaceuticals Corp. · Granted Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10800753

Tetrahydrothiophene-based GABA aminotransferase inactivators and analogs thereof for treating neurological disorders

Northwestern University · Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10799512

Estrogen combination for treatment of multiple sclerosis

The Regents of the University of California · Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10774121

Methods and compositions for treating neurodegenerative disorders and Alzheimer's Disease and improving normal memory

The Regents of the University of California · Granted Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10738361

Methods of predicting clinical course and treating multiple sclerosis

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10653743

Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10610535

Diarylpropionitrile therapy for treatment of multiple sclerosis

The Regents of the University of California · Granted Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10603311

Use of pridopidine to improve cognitive function and for treating Alzheimer's disease

The Board of Regents of the University of Texas System · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10562882

Piperidine derivatives for use in the treatment or prevention of psychiatric and neurological conditions

Takeda Pharmaceutical Company Limited · Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10550157

Compositions and methods for treating central nervous system (CNS) disorders and mood disorders

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10517853

Methods for treating epilepsy

PTC THERAPEUTICS, INC. · Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10457670

Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimers disease

Takeda Pharmaceutical Company Limited · Granted Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10456373

Agent exhibiting anti-stress, anxiolytic and anti-depression activity, and composition based thereon

OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU “NORMOFARM” · Granted Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10450275

Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain

The Board of Regents of the University of Texas System · Granted Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10441580

Iloperidone for the treatment of schizophrenia

VANDA PHARMACEUTICALS INC. · Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10407374

Compositions and methods for ameliorating CNS inflammation, psychosis, delirium, PTSD or PTSS

The Regents of the University of California · Granted Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10407495

Bispecific antibody fragments for neurological disease proteins and methods of use

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10363245

Methods for treating CNS lesions

The Board of Regents of the University of Texas System · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10357217

Method for positron emission tomography (PET) imaging analysis for classifying and diagnosing of neurological diseases

The Regents of the University of California · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10351589

3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treatment of CNS disorders

Umecrine Cognition AB · Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10336732

1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders

PGI Drug Discovery LLC · Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10335466

AADC polynucleotides for the treatment of parkinson's disease

VOYAGER THERAPEUTICS, INC. · Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10301393

Methods of treating multiple sclerosis using anti-CD20 antibodies

VACCINEX, INC. · Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10265338

Compounds and methods for treating neurological and cardiovascular conditions

The Board of Regents of the University of Texas System · Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10233222

Methods, compositions, diagnostics and assays for the treatment of Alzheimer's disease

The Regents of the University of Colorado, a Body Corporate · Granted Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10221223

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

The Regents of the University of California · Granted Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10206921

Methods and compositions for treating a subject for central nervous system (CNS) injury

The Regents of the University of California · Granted Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10188650

Treatment of neurological disorders

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10183011

Anti-depression compounds

The Board of Regents of the University of Texas System · Granted Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10167314

Methods of treating depression and other related diseases

Northwestern University · Granted Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10149853

Stabilized formulations of CNS compounds

Supernus Pharmaceuticals, Inc. · Granted Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117907

Glycosylated PACAP/VIP analogues with enhanced CNS penetration for treatment of neurodegenerative diseases

Arizona Board of Regents on Behalf of the University of Arizona, a body corporate · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10098540

Hyperspectral imaging for detection of Parkinson's disease

Regents of the University of Minnesota · Granted Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10100367

Diagnosing and monitoring CNS malignancies using microRNA

The Regents of the University of California · Granted Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10071095

1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders

Addex Pharma, S.A. · Granted Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)